USADA suspended the women’s bantamweight athlete two years for testing positive for the steroid, our news outlet has learnt.
Amanda Lemos is the latest fighter to be suspended by USADA for a UFC anti-doping policy violation.
USADA suspended the women’s bantamweight athlete two years for testing positive for the steroid stanozolol and its metabolite, stemming from an out-of-competition sample collected Nov. 8, 2017, the UFC’s anti-doping partner announced Wednesday. Lemos won’t be eligible to fight again in the UFC until November 2019.
Lemos (6-1-1) made her UFC debut at UFC Glasgow last July. The Brazilian fighter fell on that card to Leslie Smith via second-round TKO. Lemos, 30, was undefeated heading into that bout, a rising prospect coming from the Jungle Fight promotion in Brazil.
Lemos is one of four fighters to test positive for stanozolol since USADA began leading the UFC’s anti-doping program in 2015. Carlos Felipe, Viscardi Andrade and Guido Cannetti were the others. All of them hail from South America.